Granuloma - 203 Studies Found
Terminated |
: CHUSPAN SCS BP Treatment of Churg–Strauss Syndrome Without Poor-Prognosis Factors : Churg-Strauss Syndrome : 2006-11-13 :
|
Completed |
: Safety and Efficacy Study of Mepolizumab in Churg Strauss Syndrome : Churg Strauss Syndrome : 2008-07-14 : Drug: mepolizumab 750 mg mepolizumab iv q4wk until week 32 |
Not yet recruiting |
: Immuno-ablation With Chemoimmunoradiation and Autologous Stem Cell Transplant for Churg-Strauss Syndrome : Churg-Strauss Syndrome : 2016-03-14 : Biological: HPC cell infusion Administration of total lymp |
Not yet recruiting |
: Reslizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study : Asthma : 2016-10-17 : Drug: Reslizumab All subjects will receive Reslizumab |
Completed |
: Association Corticosteroid/Azathioprine in Microscopic Polyangiitis/ Polyarteritis Nodosa or Eosinophilic Granulomatosis With Polyangiitis (Churg Strauss Syndrome) :
|
Recruiting |
: Benralizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study : Asthma : 2016-12-11 : Drug: Benralizumab one injection 30 mg under the subjects skin every 4 weeks for 8 weeks and then every |
Recruiting |
: PRO Development for ANCA Associated Vasculitis :
|
Completed |
: RATTRAP: Infliximab Versus Rituximab in Systemic Necrotizing Vasculitides :
: |
Completed |
: Cyclophosphamide Versus Methotrexate for Remission Maintenance in Systemic Necrotizing Vasculitides :
: |
Completed |
: Anti-Interleukin-5 (IL-5) Study for Hypereosinophilic Syndrome :
|